Neostibosan
| Code | Size | Price |
|---|
| TAR-T33637-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Neostibosan is an arsenic-containing parasitic agent. Due to the activity of arsenic on visceral L/Ashmaniasis, one of the pentvalent antimony, which is less toxic, is synthesized and has potential activity on tumor cells.
CAS:
554-76-7
Formula:
C6H8NO3Sb
Molecular Weight:
263.894
Purity:
0.98
SMILES:
Nc1ccc(cc1)[Sb](O)(O)=O
References
IVADY G, FRIEDRICH E. [Comparative studies on the efficacy of pentamidine, Solustibosan and Neostibosan against Candida albicans]. Dtsch Gesundheitsw. 1960 Oct 27;15:2130-2. German. PubMed PMID: 13718206.
Cambronero Galache M, Mart?nez Cort?s F, B?dalo Herrero A, Courel Grijalba A, Casado Flores J, Casquero Junquera J. [Kala-azar in childhood. 20 year review]. An Esp Pediatr. 1983 Jan;18(1):28-32. Spanish. PubMed PMID: 6870075.
Duke BO. The effects of drugs on Onchocerca volvulus. 2. The antimonial preparations TWSb and MSbE. Bull World Health Organ. 1968;39(2):147-55. PubMed PMID: 4881067; PubMed Central PMCID: PMC2554559.
Hadjikakou SK, Ozturk II, Banti CN, Kourkoumelis N, Hadjiliadis N. Recent advances on antimony(III/V) compounds with potential activity against tumor cells. J Inorg Biochem. 2015 Dec;153:293-305. doi: 10.1016/j.jinorgbio.2015.06.006. Epub 2015 Jun 10. Review. PubMed PMID: 26092367.